Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Preliminary results
Quarterly results
MARAVAI LIFESCIENCES HOLDINGS, INC. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS"
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT",
"Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition William “Trey” Martin, III assumes the role of Maravai’s CEO Carl Hull to continue to serve as Executive Chairman"
07/20/2023 8-K Quarterly results
05/08/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS"
03/13/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/22/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS"
12/01/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Maravai LifeSciences Announces Updated CEO Leadership Transition Plans"
10/19/2022 8-K Quarterly results
10/03/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT",
"MARAVAI LIFESCIENCES HOLDINGS, INC. 2020 OMNIBUS INCENTIVE PLAN",
"MARAVAI LIFESCIENCES HOLDINGS, INC. 2020 OMNIBUS INCENTIVE PLAN",
"MARAVAI LIFESCIENCES HOLDINGS, INC. 2020 OMNIBUS INCENTIVE PLAN",
"AMENDMENT TO EMPLOYMENT AGREEMENT",
"Maravai LifeSciences Announces CEO Leadership Transition -William “Trey” Martin, III appointed to succeed Carl Hull as Chief Executive Officer - Hull to Serve as Executive Chairman of the Board of Directors"
08/04/2022 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS"
05/16/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS"
02/23/2022 8-K Quarterly results
01/28/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s Trilink mRNA technologies"
01/03/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
11/10/2021 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS THIRD QUARTER FINANCIAL RESULTS, UPDATES 2021 FINANCIAL GUIDANCE AND PROVIDES PRELIMINARY REVENUE GUIDANCE FOR 2022"
08/10/2021 8-K Quarterly results
Docs: "as Seller, VOYAGER GROUP HOLDINGS, INC.,",
"MARAVAI LIFESCIENCES REPORTS SECOND QUARTER FINANCIAL RESULTS AND UPDATES 2021 FINANCIAL GUIDANCE"
05/20/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/10/2021 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FIRST QUARTER FINANCIAL RESULTS AND UPDATES 2021 FINANCIAL GUIDANCE"
04/05/2021 8-K Preliminary quarterly results
Docs: "MARAVAI LIFESCIENCES ANNOUNCES PRELIMINARY UNAUDITED FIRST QUARTER REVENUES AND INCOME FROM OPERATIONS RANGE"
03/02/2021 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND INITIATES 2021 FINANCIAL GUIDANCE"
11/25/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : November 19, 2020 Maravai LifeSciences Holdings, Inc. Delaware 001-39725 85-2786970 10770 Wateridge Circle Suite 200 San Diego, California 92121 546-0004 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communicati...",
"Underwriting Agreement, among Maravai LifeSciences Holdings, Inc., Maravai Topco Holdings, LLC and Morgan Stanley & Co. LLC, Jefferies LLC and Goldman Sachs & Co. LLC, as representatives for the underwriters named therein",
"Amended and Restated Certificate of Incorporation of Maravai LifeSciences Holdings, Inc.",
"Amended and Restated Bylaws of Maravai LifeSciences Holdings, Inc.",
"Registration Rights Agreement, by and among Maravai LifeSciences Holdings, Inc. and the other signatories party thereto",
"Tax Receivable Agreement, by and among Maravai LifeSciences Holdings, Inc. and the other signatories party thereto",
"Exchange Agreement, by and among Maravai LifeSciences Holdings, Inc. and the other signatories party thereto",
"Second Amended and Restated Limited Liability Agreement of Maravai Topco Holdings, LLC, by and among Maravai LifeSciences Holdings, Inc. and the other signatories party thereto",
"Director Nomination Agreement, by and among Maravai LifeSciences Holdings, Inc. and the other signatories party thereto",
"Employment Agreement of Carl W. Hull, among Maravai LifeSciences Holdings, Inc., Maravai Intermediate Holdings, LLC and Carl W. Hull",
"Employment Agreement of Kevin Herde, among Maravai LifeSciences Holdings, Inc., Maravai Intermediate Holdings, LLC and Kevin Herde"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy